As of 2025-11-18, the Intrinsic Value of QuiaPEG Pharmaceuticals Holding AB (QUIA.ST) is -0.06 SEK. This QUIA.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 SEK, the upside of QuiaPEG Pharmaceuticals Holding AB is -2,636.32%.
Based on its market price of 0.00 SEK and our intrinsic valuation, QuiaPEG Pharmaceuticals Holding AB (QUIA.ST) is overvalued by 2,636.32%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -2,636.32% |
| P/E | (0.33) - (0.35) | (0.30) | -12299.7% |
| DDM - Stable | (0.33) - 0.58 | 0.12 | 4820.4% |
| DDM - Multi | (0.40) - 0.56 | (3.12) | -124977.3% |
| Market Cap (mil) | 5.52 |
| Beta | -3.73 |
| Outstanding shares (mil) | 2,209.26 |
| Enterprise Value (mil) | 5.52 |
| Market risk premium | 5.10% |
| Cost of Equity | 4.35% |
| Cost of Debt | 5.00% |
| WACC | 4.32% |